Results 11 to 20 of about 34,942 (245)

6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy [PDF]

open access: yesHuman Genomics, 2012
The Golden Helix Pharmacogenomics Days are international scientific meetings aiming to educate healthcare professionals and biomedical scientists about pharmacogenomics and personalized medicine.
Stojiljkovic Maja   +6 more
doaj   +5 more sources

Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives [PDF]

open access: yesPharmacogenomics and Personalized Medicine, 2016
Jai N Patel Department of Cancer Pharmacology, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA Abstract: Cancer pharmacogenomics is an evolving landscape and has the potential to significantly impact cancer care and precision ...
Patel JN
doaj   +1 more source

Pharmacogenomics [PDF]

open access: yes, 2022
This Special Issue focuses on the current state of pharmacogenomics (PGx) and the extensive translational process, including the identification of functionally important PGx variation; the characterization of PGx haplotypes and metabolizer statuses ...

core   +1 more source

Pharmacogenomics of oxycodone: a narrative literature review [PDF]

open access: yes, 2021
Oxycodone is a semisynthetic μ- and κ-opioid receptor with agonist with a broad scope of use including postoperative analgesia as well as control of neuropathic and cancer pain.
Rossos, Ryan   +5 more
core   +1 more source

British South Asian ancestry participants views of pharmacogenomics clinical implementation and research: a thematic analysis. [PDF]

open access: yes, 2023
BACKGROUND: South Asian ancestry populations are underrepresented in genomic studies and therapeutics trials. British South Asians suffer from multi-morbidity leading to polypharmacy.
Islam, MR   +7 more
core   +1 more source

Pharmacogenomics Implementation Across Multiple Clinic Settings: A Qualitative Evaluation [PDF]

open access: yes, 2023
Aim: To advance clinical adoption and implementation of pharmacogenomics (PGx) testing, barriers and facilitators to these efforts must be understood. This study identified and examined barriers and facilitators to active implementation of a PGx program ...
Rowe, Elizabeth   +7 more
core   +1 more source

Conference scene : Golden Helix Pharmacogenomics Days : educational activities on pharmacogenomics and personalized medicine [PDF]

open access: yes, 2012
The Golden Helix Pharmacogenomics Days are high-profile international educational scientific meetings discussing pharmacogenomics and personalized medicine.
Borg, Joseph J.   +5 more
core   +1 more source

Tailoring therapy for heart failure: the pharmacogenomics of adrenergic receptor signaling [PDF]

open access: yes, 2014
Grazia Daniela Femminella,1 Vincenzo Barrese,2,3 Nicola Ferrara,1,4 Giuseppe Rengo4 1Department of Translational Medical Sciences, Federico II University, Naples, Italy; 2Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II
Ferrara, N   +11 more
core   +1 more source

Pharmacogenovigilance: a pharmacogenomics pharmacovigilance program [PDF]

open access: yes, 2014
In this report, we review the importance of pharmacovigilance in detecting postmarketing adverse drug events and the potential for developing pharmacogenovigilance programs by integrating pharmacogenomics with pharmacovigilance.
Khoueiry-Zgheib, Nathalie, Awada, Zainab
core   +1 more source

Classical twin design in modern pharmacogenomics studies. [PDF]

open access: yes, 2020
Response to medication is highly variable, unpredictable and, at times, may be fatal. All drugs are more effective in certain groups of the population while showing no or minimal benefit in other groups.
Rahmioğlu, N, Ahmadi, KR
core   +1 more source

Home - About - Disclaimer - Privacy